NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/30/2026
Back to search
Official data from USPTO
AKERO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
03/31/2026
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
08/22/2018
Registration date
12/22/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/25/2018
First use in commerce
2018-07-00
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
LEE, JANET H
Current location
Historical data usage
Mark description
The mark consists of the stylized wording "AKERO", where the letters, "A", "K", "R", and, "O" are in lowercase letter and the letter "E" shown as three horizontal lines, where the middle bar is depicted as an arrow and a small circle is to the left of the arrow.
Holders and representatives
Holders
Akero Therapeutics, Inc.
Akero Therapeutics, Inc.
Representatives
Tiffany D. Gehrke Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals; clinical research in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
48 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/30/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/30/2026
E815
TEAS SECTION 8 & 15 RECEIVED
01/06/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/22/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/07/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/01/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/01/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/22/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/20/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/19/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
11/19/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/05/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/28/2020
DRRR
DIVISIONAL REQUEST RECEIVED
09/28/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/28/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/28/2020
EX1G
SOU EXTENSION 1 GRANTED
03/26/2020
EXT1
SOU EXTENSION 1 FILED
03/26/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/26/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/19/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
ALIE
ASSIGNED TO LIE
07/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/10/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
12/13/2018
GPRA
PRIORITY ACTION E-MAILED
12/13/2018
CPRA
PRIORITY ACTION WRITTEN
12/13/2018
DOCK
ASSIGNED TO EXAMINER
12/07/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/31/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2018
NWAP
NEW APPLICATION ENTERED
08/25/2018
Continuous trademark protection
Get notified about every new filing that threatens AKERO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.